Literature DB >> 22252814

Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients.

Krystina L Woods, James R Johnson, Sofia Padkowsky, Noriel Mariano, Rita Colon-Urban, Mahmoud Hassanein, Wehbeh Wehbeh, Brian D Johnston, Connie Clabots, Saadia Zahid, Carl Urban.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22252814      PMCID： PMC3318390          DOI： 10.1128/AAC.00003-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  CTX-M-3 and CTX-M-15 extended-spectrum beta-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria.

Authors:  Nadjia Ramdani-Bouguessa; Nuno Mendonça; Joana Leitão; Eugénia Ferreira; Mohamed Tazir; Manuela Caniça
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

Review 2.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Authors:  Johann D D Pitout; Kevin B Laupland
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

3.  CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy.

Authors:  Sophie Boyer-Mariotte; Pauline Duboc; Stéphane Bonacorsi; Jean-François Lemeland; Edouard Bingen; Didier Pinquier
Journal:  J Antimicrob Chemother       Date:  2008-09-04       Impact factor: 5.790

4.  Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death.

Authors:  Robert C Owens; James R Johnson; Patricia Stogsdill; Lonny Yarmus; Karen Lolans; John Quinn
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

5.  Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States.

Authors:  James R Johnson; Brian Johnston; Connie Clabots; Michael A Kuskowski; Mariana Castanheira
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

6.  Identification of CTX-M beta-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities.

Authors:  Carl Urban; Noriel Mariano; Patricia A Bradford; Margareta Tuckman; Sorana Segal-Maurer; Wehbeh Wehbeh; Louise Grenner; Rita Colon-Urban; Brian Johnston; James R Johnson; James J Rahal
Journal:  Diagn Microbiol Infect Dis       Date:  2010-04       Impact factor: 2.803

7.  Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City.

Authors:  Hemavarna Tiruvury; James R Johnson; Noriel Mariano; Louise Grenner; Rita Colon-Urban; Mohamed Erritouni; Wehbeh Wehbeh; Sorana Segal-Maurer; James J Rahal; Brian Johnston; Carl Urban
Journal:  Diagn Microbiol Infect Dis       Date:  2012-01-17       Impact factor: 2.803

8.  Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.

Authors:  Marie-Hélène Nicolas-Chanoine; Jorge Blanco; Véronique Leflon-Guibout; Raphael Demarty; Maria Pilar Alonso; Maria Manuela Caniça; Yeon-Joon Park; Jean-Philippe Lavigne; Johann Pitout; James R Johnson
Journal:  J Antimicrob Chemother       Date:  2007-12-11       Impact factor: 5.790

9.  Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004.

Authors:  James R Johnson; Megan Menard; Brian Johnston; Michael A Kuskowski; Kim Nichol; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

10.  Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.

Authors:  O K Azap; H Arslan; K Serefhanoğlu; S Colakoğlu; H Erdoğan; F Timurkaynak; S S Senger
Journal:  Clin Microbiol Infect       Date:  2009-08-18       Impact factor: 8.067
  10 in total
  4 in total

1.  Identification of extended-spectrum-β-lactamase-positive Klebsiella pneumoniae urinary tract isolates harboring KPC and CTX-M β-lactamases in nonhospitalized patients.

Authors:  Joanna Kopacz; Noriel Mariano; Rita Colon-Urban; Paul Sychangco; Wehbeh Wehbeh; Sorana Segal-Maurer; Carl Urban
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

2.  Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.

Authors:  Theresa Madigan; James R Johnson; Connie Clabots; Brian D Johnston; Stephen B Porter; Billie S Slater; Ritu Banerjee
Journal:  Clin Infect Dis       Date:  2015-03-31       Impact factor: 9.079

3.  Guiding Empiric Treatment for Serious Bacterial Infections via Point of Care [Formula: see text]-Lactamase Characterization.

Authors:  Akilan Palanisami; Shazia Khan; Sultan Sibel Erdem; Tayyaba Hasan
Journal:  IEEE J Transl Eng Health Med       Date:  2016-06-29       Impact factor: 3.316

4.  Gut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli.

Authors:  Emily A Gurnee; I Malick Ndao; James R Johnson; Brian D Johnston; Mark D Gonzalez; Carey-Ann D Burnham; Carla M Hall-Moore; Jessica E McGhee; Alexander Mellmann; Barbara B Warner; Phillip I Tarr
Journal:  J Infect Dis       Date:  2015-05-12       Impact factor: 5.226
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.